January 20th 2025
The novel therapeutic demonstrated a strong safety profile and showed efficacy in reducing symptoms during the early stages of treatment.
December 18th 2024
Your daily dose of the clinical news you may have missed.
November 29th 2024
Your daily dose of the clinical news you may have missed.
November 13th 2024
Little action has been taken by state medical boards against clinicians who spread unsubstantiated claims about COVID-19, vaccines, or other pandemic-related topics.
November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
2 Commerce Drive
Cranbury, NJ 08512